View

Oct 1, 2024, 04:05 AM by Margaret Fontana

ISPOR announced the publication of a study that provides estimates of how the Centers for Medicare & Medicaid Services (CMS) may have determined initial price offers for the first 10 drugs selected for Medicare price negotiation. A prepublication version of the study was released online on the same day the CMS announced it reached agreements for lower drug prices.

Sep 23, 2024, 04:05 AM by Margaret Fontana

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for ISPOR Europe 2024. The conference is the leading European conference for health economics and outcomes research (HEOR) and is scheduled for 17-20 November in Barcelona, Spain with the theme, “Generating Evidence Toward Health and Well-Being.”

Jul 29, 2024, 04:05 AM by B Lane

ISPOR announced its new Strategic Plan 2030 that presents a bold new vision for the Society and the field of health economics and outcomes research (HEOR).

Jul 9, 2024, 04:05 AM by Margaret Fontana

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Jun 18, 2024, 04:05 AM by Margaret Fontana

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

Jun 17, 2024, 04:05 AM by Margaret Fontana

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.

May 28, 2024, 04:05 AM by B Lane

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the results of its recent elections. The Society’s membership selected its new president-elect and 4 new board members. The 2024-2025 board will assume office on July 1.

May 13, 2024, 04:05 AM by Margaret Fontana

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of a report from the ISPOR Biosimilars Special Interest Group highlighting the need for clearer guidance on when and how to conduct health technology assessments (HTAs) for biosimilars.

Apr 23, 2024, 04:05 AM by B Lane

ISPOR announced the sessions and speakers for its Patient-Centered Research Summit 2024. The Summit is scheduled to be held May 5 in Atlanta, GA, USA and is co-located with the Society’s annual international conference, ISPOR 2024.

Apr 22, 2024, 04:05 AM by B Lane

ISPOR announced the plenary sessions and speakers for ISPOR 2024, its annual international conference and the leading global conference for health economics and outcomes research (HEOR). ISPOR 2024 will be held May 5-8 in Atlanta, GA, USA.

Apr 9, 2024, 04:05 AM by Margaret Fontana

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of a report from the ISPOR Digital Health Special Interest Group that proposes a new framework to help standardize and clarify definitions used for digital health interventions. The report, “The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report” was published in the April 2024 issue of Value in Health.

Apr 2, 2024, 04:05 AM by B Lane

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced that it has launched a new microsite that provides HEOR information and resources organized by topical areas of interest—HEOR by Topic.

Feb 26, 2024, 04:05 AM by Margaret Fontana

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the publication of a new report from the ISPOR Medication Adherence and Persistence Special Interest Group revealing significant inconsistencies in how researchers measure the effectiveness of interventions aimed at improving medication adherence. The report, “A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report” was published in the February 2024 issue of Value in Health.

Jan 29, 2024, 04:05 AM by B Lane

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced that it has launched its new online learning platform for HEOR education and training—ISPOR Education Center.

Jan 23, 2024, 04:05 AM by Margaret Fontana

Value in Health Regional Issues, an official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the expansion of its editorial scope and its plan to transition to a gold open access journal.

Jan 22, 2024, 04:05 AM by B Lane

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that highlight innovative approaches to improving health outcomes in low- and middle-income countries through partnerships between health economics researchers and policy makers.

Jan 16, 2024, 04:00 AM by B Lane

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced the publication of its “2024-2025 Top 10 HEOR Trends Report.” The Society publishes this report as part of its horizon scanning and monitoring of the trends that affect healthcare decision making around the world.

Dec 18, 2023, 00:00 AM by B Lane

ISPOR announced the appointment of Nancy J. Devlin, PhD, University of Melbourne, Australia as an editor-in-chief for Value in Health.

Dec 11, 2023, 04:05 AM by B Lane

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that Mitch Higashi, PhD has joined the Society’s leadership team as Associate Chief Science Officer.

Dec 5, 2023, 04:05 AM by B Lane

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.